Jade Biosciences Inc. (JBIO)
NASDAQ: JBIO
· Real-Time Price · USD
8.86
0.53 (6.36%)
At close: Oct 03, 2025, 3:59 PM
8.35
-5.76%
After-hours: Oct 03, 2025, 05:57 PM EDT
Jade Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
Cash & Equivalents | 220.94M | 44.22M | 33.75M | 87.97M | 31.07M | 9.12M | 23.49M | 32.18M |
Short-Term Investments | n/a | 31.99M | 44.87M | 57.62M | 73.13M | 90.21M | 98.95M | 103.02M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 60K | n/a | n/a | 1.16M | 81K | 2.6M | 2.28M | 2.24M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.04M | 845K | 845K | -542K | 452K | 304K | 250K | 567K |
Total Current Assets | 222.98M | 77.37M | 80.12M | 88.19M | 110.76M | 103.24M | 124.23M | 137.6M |
Property-Plant & Equipment | 924K | 160K | 215K | n/a | 853K | 985K | 902K | 1.03M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 984K | 160K | 215K | 1.16M | 934K | 3.58M | 3.19M | 3.27M |
Total Assets | 223.97M | 77.53M | 80.33M | 89.35M | 111.69M | 106.82M | 127.42M | 140.88M |
Account Payables | 7.59M | 69K | 224K | 923K | 4.18M | 3.31M | 2.4M | 3.5M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | 312K | 417K | 459K | 475K | 445K | 420K | 451K |
Other Current Liabilities | 5.35M | 429K | 319K | -379K | 9.7M | 10.43M | 10.45M | 8.12M |
Total Current Liabilities | 21.62M | 2.42M | 3.83M | 9.48M | 17.02M | 15.52M | 17.64M | 14.72M |
Long-Term Debt | n/a | n/a | n/a | 96.7M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 70K | 70K | 26K | 70K | 70K | 70K | 70K |
Total Long-Term Liabilities | 792K | 70K | 70K | 96.73M | 276K | 399K | 325K | 428K |
Total Liabilities | 22.41M | 2.49M | 3.9M | 106.21M | 17.3M | 15.92M | 17.96M | 15.15M |
Total Debt | 792K | 312K | 417K | 96.7M | 681K | 774K | 675K | 809K |
Book Value | 201.56M | 75.05M | 76.43M | -16.86M | 94.4M | 90.9M | 109.46M | 125.72M |
Book Value Per Share | 7.09 | 90.62 | 92.30 | -20.45 | 114.90 | 114.46 | 138.33 | 159.20 |
Common Stock | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -117.28M | -235.57M | -233.05M | -227.62M | -211.38M | -186.61M | -163.42M | -143.01M |
Comprehensive Income | -24K | 50K | 105K | 224K | -83K | -33K | 237K | -195K |
Shareholders Equity | 201.56M | 75.05M | 76.43M | 80.49M | 94.4M | 90.9M | 109.46M | 125.72M |
Total Investments | n/a | 31.99M | 44.87M | 57.62M | 73.13M | 90.21M | 98.95M | 103.02M |